MedTrace Logo

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

NCT00003031 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2012-07-02

No results posted yet for this study

Summary

RATIONALE: Antifungal therapy with voriconazole or amphotericin B may be an effective treatment for aspergillosis. It is not yet known whether voriconazole is more effective than amphotericin B in treating patients with aspergillosis.

PURPOSE: Randomized phase III trial to compare the effectiveness of voriconazole with amphotericin B in treating patients with aspergillosis.

Conditions

Interventions

DRUG

amphotericin B deoxycholate

DRUG

voriconazole

Sponsors & Collaborators

  • European Organisation for Research and Treatment of Cancer - EORTC

    lead NETWORK

Principal Investigators

  • R. Herbrecht, MD · Hopital Universitaire Hautepierre

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-06-30
Primary Completion
2000-10-31

Countries

  • United States
  • Australia
  • Belgium
  • France
  • Germany
  • Hungary
  • Ireland
  • Israel
  • Italy
  • Luxembourg
  • Netherlands
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003031 on ClinicalTrials.gov